Search clinical trials for: IrisFIT PFO Occluder

Total 3166 results

Lifetech Scientific (Shenzhen) Co., Ltd.

Completed

Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale) Occluder (PFO)

Patent Foramen Ovale

Ireland, Germany
China National Center for Cardiovascular Diseases

Recruiting

Cerebral Microembolization Associated With PFO Closure

Thrombosis Cardiac

China
Occlutech International AB

Active, not recruiting

The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO (PROOF)

Stroke | PFO - Patent Foramen Ovale

France, Germany, Italy, Canada
Abbott Medical Devices

Active, not recruiting

Amplatzer PFO Occluder Post-marketing Surveillance Study (PFO PMS Jpn)

PFO - Patent Foramen Ovale

Japan
Abbott Medical Devices

Recruiting

AMPLATZER PFO Occluder Post Approval Study (PFO PAS)

Stroke | Patent Foramen Ovale

United States, Germany, Canada, Switzerland, Italy, Portugal, United Kingdom
Hangzhou Dinova EP Technology Co., Ltd

Not yet recruiting

Study on the Safety and Effectiveness of the SnowyTM PFO Closure System

Patent Foramen Ovale

China
Abbott Medical Devices

Completed

PREMIUM Migraine Trial

Patent Foramen Ovale | Migraine Headaches

United States
Abbott Medical Devices

Terminated

PRIMA PFO Migraine Trial (PRIMA)

Migraine | Patent Foramen Ovale | Migraine With Aura | PFO

United Kingdom, Germany, Canada, Switzerland
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

Lifetech Cera™ PFO Occluder Post-Market Clinical Follow-Up

Patent Foramen Ovale | PFO

Poland
SeptRx, Inc.

Unknown

InterSEPT: In-Tunnel SeptRx European PFO Trial (InterSEPT)

Heart Septal Defects | Heart Defects, Congenital | Foramen Ovale, Patent

Germany, France
Abbott Medical Devices

Approved for marketing

Emergency/Compassionate Use PFO Occluder

Patent Foramen Ovale | PFO
Abbott Medical Devices

No longer available

PFO ACCESS Registry

Stroke | Patent Foramen Ovale
W.L.Gore & Associates

Recruiting

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study (REDUCE PAS)

Stroke | PFO - Patent Foramen Ovale

United States
pfm medical ag
Aix Scientifics

Completed

Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System (pfm-01/2005)

Heart Septal Defects, Ventricular

Germany, Israel
Nobles Medical Technologies II Inc

Suspended

NobleStitch EL STITCH Trial is a PFO Comparative Trial (STITCH)

Foramen Ovale, Patent | Stroke, Ischemic

United States, Italy
Nobles Medical Technologies II Inc

Enrolling by invitation

Stitch Closure of PFO and Septal Repair (STITCH)

Foramen Ovale, Patent | Septal Defect, Atrial | Septal Defect, Heart

United States, Italy
pfm medical ag
MDT Medical Device Testing GmbH

Completed

Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System (09k003)

Heart Septal Defects, Atrial | Foramen Ovale, Patent | Heart Catheterization

Germany
Abbott Medical Devices

Recruiting

Trevisio Post-Approval Study (TrevisioPAS)

PFO - Patent Foramen Ovale | VSD - Muscular Ventricular Septal Defect | PIVSD - Post Infarct Muscular Ventricular Septal Defect | ASD - Atrial Septal Defect

Spain, Germany, Poland, France, Italy, Netherlands, Switzerland
Gachon University Gil Medical Center

Completed

Residual Shunt After Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke

Patent Foramen Ovale | Closure; Foramen Ovale

Korea, Republic of
Chinese Academy of Medical Sciences, Fuwai Hospital

Not yet recruiting

A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine (BioMetal)

Migraine | Migraine Headache | PFO - Patent Foramen Ovale | Migraine Headache, With or Without Aura

China
Queen's University

Completed

The Retention Rate Between Brand A and Brand B Punctal Plugs

Dry Eye

Canada
Abbott Medical Devices

Terminated

ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study (ASO 522)

Atrial Septal Defect Secundum

United States
Pfizer

Terminated

A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device

Healthy Volunteers

Belgium
Abbott Medical Devices

Active, not recruiting

Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study (VPA)

Ventricular Septal Defects

United States, Canada
Medtronic Cardiovascular

Terminated

Talent Converter Post-Approval Study

Abdominal Aortic Aneurysms
University of Sao Paulo
W.L.Gore & Associates; InCor Heart Institute

Terminated

Endoscopic Closure of Tracheoesophageal Fistulas With Occluder Device (TEFGoreHelex)

Acquired Tracheo-esophageal Fistula

Brazil
Lifetech Scientific (Shenzhen) Co., Ltd.
IQVIA Biotech

Active, not recruiting

Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study (LISA)

Atrial Fibrillation

China, Denmark, Germany, Ireland, Italy, Poland, Spain, Sweden, Thailand
Shanghai Zhongshan Hospital

Recruiting

The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial)

Atrial Septal Defect

China
atHeart Medical

Recruiting

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD (ASCENT ASD)

Heart Diseases | Cardiovascular Diseases | Congenital Abnormalities | Heart Septal Defects, Atrial | Heart Defects, Congenital | Cardiovascular Abnormalities | Heart Septal Defect

United States, France
Xijing Hospital
The First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaborators

Not yet recruiting

Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology (RECORD)

Non-valvular Atrial Fibrillation

China
Occlutech International AB

Completed

Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus

Patent Ductus Arteriosus

Malaysia, Vietnam
Abbott Medical Devices
Japanese society of Congenital Interventional Cardiology

Recruiting

Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance

Patent Ductus Arteriosus

Japan
Carag AG

Completed

Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen Ovale

Atrial Septal Defect | Patent Foramen Ovale

Germany
Pfizer

Completed

A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects (B538-05)

Healthy Subjects

United States
Abbott Medical Devices

Completed

Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study

Atrial Septal Defect

United States
University Health Network, Toronto
St. Paul's Hospital, Canada; Montreal Heart Institute; Centre de Recherche de...

Recruiting

Comparison of Devices for Atrial Septal Defects Closure: A Pilot Study (Trio-ASD)

Atrial Septal Defect

Canada
Heart Center Leipzig - University Hospital

Active, not recruiting

MitraClip® and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure

Mitral Valve Insufficiency | Heart Septal Defects, Atrial

Germany
Abbott Medical Devices

Completed

Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER

Membranous Ventricular Septal Defects

United States
Abbott Medical Devices

Completed

AMPLATZER Duct Occluder II Clinical Study (ADO II)

Patent Ductus Arteriosus

United States
Abbott Medical Devices

Approved for marketing

Emergency/Compassionate Use - Muscular VSD Occluder

Ventricular | Septal | Defects | VSD | Muscular
W.L.Gore & Associates

Recruiting

Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder (GSO-PFO PMS)

Stroke | TIA | Cryptogenic Stroke | PFO - Patent Foramen Ovale

Japan
W.L.Gore & Associates

Completed

Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects

Septal Defect, Atrial

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Transcaval Access for Transcatheter Aortic Valve Replacement in People With No Good Options for Aortic Access

Aortic Valve Stenosis

United States
Abbott Medical Devices

Completed

Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial

Cryptogenic Stroke

United States, Canada
Eclipse Medical Ltd.
KCRI

Recruiting

Evaluation od Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk (Omega)

Non-Valvular Atrial Fibrillation

Denmark, Germany, Italy, Spain, United Kingdom
Lifetech Scientific (Shenzhen) Co., Ltd.

Completed

Lifetech KONAR MFO Post-Market Clinical Follow-Up Study

Ventricular Septal Defect

Italy, Germany
W.L.Gore & Associates

Completed

Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs (ASSURED)

Atrial Septal Defect

United States
Cardiac Children's Foundation Taiwan

Recruiting

Cera™ VSD Occluder Post Market Clinical Follow-up

Ventricular Septal Defect

Taiwan
National Research Center for Preventive Medicine
I.M. Sechenov First Moscow State Medical University; National Medical Research... and other collaborators

Completed

Non-pharmacological Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation

Atrial Fibrillation

Russian Federation
W.L.Gore & Associates

Completed

Long-term Safety Study of the GORE® HELEX® Septal Occluder

Septal Defect, Atrial

United States

Search clinical trials for: IrisFIT PFO Occluder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations